FIELD: medicine, pharmacy.
SUBSTANCE: invention describes oral medicinal formulation of sustained-release hydrocodon (variants). The medicinal formulation comprises amount of hydrocodon or its pharmaceutically acceptable salt providing analgetic effect, from 0.5 mg to 1250 mg, and a substance used for the sustained releasing that is sufficient for providing medicinal formulation state allowing its administration in patient two times per 24 h. Medicinal form provides the average ratio C12/Cmax from 0.55 to 0.85 being the indicated medicinal formulation provides the therapeutic effect for at least 12 h. Invention provides enhancing effectiveness and quality of pain control in patients suffering with the moderate pain.
EFFECT: valuable pharmaceutical properties of formulation.
42 cl, 3 dwg, 23 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
COMBINATIONS OF AGONIST/ANTAGONIST FOR OPIOID | 1998 |
|
RU2241458C2 |
SYNERGETIC ANALGETIC COMBINATION OF OPIOID ANALGETIC AGENT AND CYCLOOXYGENASE-2 INHIBITOR | 1998 |
|
RU2232600C2 |
METHOD FOR PREVENTION ABUSE WITH OPIOID- -CONTAINING MEDICINAL FORMULATIONS | 1998 |
|
RU2228180C2 |
PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2445077C2 |
METHOD FOR RELIEVING ALCOHOL CONSUMPTION SYMPTOMS | 2008 |
|
RU2526157C2 |
APPLICATION OF METHYL NALTREXONE FOR TREATING IRRITABLE COLON SYNDROME | 2004 |
|
RU2373936C2 |
FORMULATIONS OF NON-OPIOID AND LIMITED OPIOID ANALGESICS | 2007 |
|
RU2477995C2 |
GUANFACINE-BASED PHARMACEUTICAL COMPOSITIONS, SUITABLE FOR DAILY INTRODUCTION IN FORM OF SINGLE DOSED FORM | 2006 |
|
RU2435573C2 |
MEDICAL FORM AND METHOD FOR DELIVERY OF HABIT-FORMING MEDICAL SUBSTANCES | 2007 |
|
RU2433817C2 |
Authors
Dates
2004-06-20—Published
2000-10-30—Filed